Korea could save $6 million foreign exchange with suture:
This article was originally published in Clinica
Sanyang has developed an absorbable suture material made from glycocolide. The product, named Surgisorb, is the first such product made domestically and South Korea could save up to Won10 billion ($6 million) by replacing foreign imports. The Korean company has already exported Won500 billion of Surgisorb to Japan, Germany, Southeast Asia and North America, according to Pharma Koreana.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.